Insulet Long Term Debt 2010-2025 | PODD

Insulet long term debt from 2010 to 2025. Long term debt can be defined as the sum of all long term debt fields.
  • Insulet long term debt for the quarter ending March 31, 2025 was $1.612B, a 18.33% increase year-over-year.
  • Insulet long term debt for 2024 was $1.296B, a 5.14% decline from 2023.
  • Insulet long term debt for 2023 was $1.366B, a 0.57% decline from 2022.
  • Insulet long term debt for 2022 was $1.374B, a 10.05% increase from 2021.
Insulet Annual Long Term Debt
(Millions of US $)
2024 $1,296
2023 $1,366
2022 $1,374
2021 $1,249
2020 $1,044
2019 $888
2018 $592
2017 $566
2016 $333
2015 $172
2014 $166
2013 $119
2012 $104
2011 $109
2010 $69
2009 $89
Insulet Quarterly Long Term Debt
(Millions of US $)
2025-03-31 $1,612
2024-12-31 $1,296
2024-09-30 $1,356
2024-06-30 $1,360
2024-03-31 $1,363
2023-12-31 $1,366
2023-09-30 $1,371
2023-06-30 $1,369
2023-03-31 $1,369
2022-12-31 $1,374
2022-09-30 $1,380
2022-06-30 $1,385
2022-03-31 $1,391
2021-12-31 $1,249
2021-09-30 $1,257
2021-06-30 $1,235
2021-03-31 $1,052
2020-12-31 $1,044
2020-09-30 $922
2020-06-30 $910
2020-03-31 $899
2019-12-31 $888
2019-09-30 $986
2019-06-30 $607
2019-03-31 $600
2018-12-31 $592
2018-09-30 $584
2018-06-30 $577
2018-03-31 $570
2017-12-31 $566
2017-09-30 $345
2017-06-30 $341
2017-03-31 $337
2016-12-31 $333
2016-09-30 $329
2016-06-30 $176
2016-03-31 $174
2015-12-31 $172
2015-09-30 $175
2015-06-30 $175
2015-03-31 $175
2014-12-31 $166
2014-09-30 $171
2014-06-30 $175
2014-03-31 $121
2013-12-31 $119
2013-09-30 $117
2013-06-30 $112
2013-03-31 $106
2012-12-31 $104
2012-09-30 $102
2012-06-30 $99
2012-03-31 $111
2011-12-31 $109
2011-09-30 $106
2011-06-30 $104
2011-03-31 $71
2010-12-31 $69
2010-09-30 $94
2010-06-30 $92
2010-03-31 $98
2009-12-31 $89
2009-09-30 $96
2009-06-30 $83
2009-03-31 $81
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $21.023B $2.072B
Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $233.364B 28.06
Stryker (SYK) United States $146.969B 30.73
Boston Scientific (BSX) United States $146.968B 36.79
EssilorLuxottica (ESLOY) France $131.277B 0.00
Medtronic (MDT) Ireland $112.813B 15.99
Lonza Group Ag (LZAGY) Switzerland $50.710B 0.00
Haleon (HLN) United Kingdom $49.016B 27.92
ResMed (RMD) United States $37.047B 27.83
Agilent Technologies (A) United States $34.235B 22.32
GE HealthCare Technologies (GEHC) United States $33.847B 16.07
Terumo (TRUMY) Japan $26.946B 35.00
Koninklijke Philips (PHG) Netherlands $22.399B 16.10
Zimmer Biomet Holdings (ZBH) United States $18.780B 12.06
Baxter (BAX) United States $16.278B 12.15
Smith & Nephew SNATS (SNN) United Kingdom $13.165B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Demant (WILYY) Denmark $8.854B 0.00
Bio-Rad Laboratories (BIO) United States $6.273B 21.83
Lantheus Holdings (LNTH) United States $5.564B 14.03
Prestige Consumer Healthcare (PBH) United States $4.281B 19.13
Perrigo (PRGO) Ireland $3.794B 9.62
Haemonetics (HAE) United States $3.466B 15.79
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.367B 24.83
Envista Holdings (NVST) United States $3.244B 26.96
GN Store Nord (GNNDY) Denmark $2.180B 18.06
QuidelOrtho (QDEL) United States $2.091B 14.38
LeMaitre Vascular (LMAT) United States $1.890B 42.24
AtriCure (ATRC) United States $1.653B 0.00
Acuren (TIC) United States $1.314B 0.00
Neogen (NEOG) United States $1.268B 16.22
AdaptHealth (AHCO) United States $1.190B 12.08
BioLife Solutions (BLFS) United States $1.136B 0.00
Green Thumb Industries (GTBIF) United States $1.063B 23.91
Kestra Medical Technologies (KMTS) United States $1.053B 0.00
Phibro Animal Health (PAHC) United States $0.987B 12.61
InMode (INMD) Israel $0.920B 9.27
CeriBell (CBLL) United States $0.640B 0.00
Evolus (EOLS) United States $0.636B 0.00
Capricor Therapeutics (CAPR) United States $0.634B 0.00
Owens & Minor (OMI) United States $0.629B 5.22
Curaleaf Holdings (CURLF) Canada $0.565B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.550B 0.00
Valneva SE (VALN) France $0.535B 0.00
Tilray Brands (TLRY) Canada $0.422B 0.00
Surmodics (SRDX) United States $0.418B 0.00
VAREX IMAGING (VREX) United States $0.367B 13.50
SNDL (SNDL) Canada $0.347B 0.00
Aurora Cannabis (ACB) Canada $0.334B 59.50
SEMPERIT AG HLD (SEIGY) Austria $0.283B 0.00
Canopy Growth (CGC) Canada $0.276B 0.00
Cerus (CERS) United States $0.275B 0.00
Viemed Healthcare (VMD) United States $0.273B 23.00
ZimVie (ZIMV) United States $0.266B 12.09
Sanara MedTech (SMTI) United States $0.265B 0.00
Sanuwave Health (SNWV) United States $0.264B 0.00
Quanterix (QTRX) United States $0.256B 0.00
Cresco Labs (CRLBF) United States $0.253B 0.00
Omeros (OMER) United States $0.227B 0.00
Biote (BTMD) United States $0.227B 6.37
OraSure Technologies (OSUR) United States $0.224B 0.00
Brainsway (BWAY) Israel $0.216B 57.30
TriSalus Life Sciences (TLSI) United States $0.211B 0.00
Organigram Global (OGI) Canada $0.191B 0.00
High Tide (HITI) Canada $0.188B 0.00
Utah Medical Products (UTMD) United States $0.186B 15.16
Verano Holdings (VRNOF) United States $0.180B 0.00
Exagen (XGN) United States $0.157B 0.00
Vireo Growth (VREOF) United States $0.133B 0.00
FitLife Brands (FTLF) United States $0.131B 16.18
MacroGenics (MGNX) United States $0.112B 0.00
Jin Medical (ZJYL) China $0.105B 0.00
Veru (VERU) United States $0.098B 0.00
Fonar (FONR) United States $0.092B 11.88
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Quipt Home Medical (QIPT) United States $0.090B 0.00
Agape ATP (ATPC) $0.079B 0.00
TerrAscend (TSNDF) Canada $0.074B 0.00
Apyx Medical (APYX) United States $0.069B 0.00
InterCure (INCR) Israel $0.067B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
Zynex (ZYXI) United States $0.066B 0.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
ImmuCell (ICCC) United States $0.057B 0.00
Modular Medical (MODD) United States $0.045B 0.00
Nephros (NEPH) United States $0.041B 55.43
United-Guardian (UG) United States $0.037B 12.94
Rockwell Medical (RMTI) United States $0.035B 0.00
Safety Shot (SHOT) United States $0.020B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Cellectar Biosciences (CLRB) United States $0.017B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
INLIF (INLF) $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00